B3: event date is not known.Please see b5 for approximate date range, if applicable.Section d references the main component of the system.Other medical products in use during the event include: brand name vectris surescan; product id 977a260, serial: (b)(6); product type: 0200-lead; implant date (b)(6) 2022; brand name vectris surescan; product id 977a260, serial: (b)(6); product type: 0200-lead; implant date (b)(6) 2022.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
Information was received from a patient via manufacturer representative who was implanted with an implantable neurostimulator (ins).Patient states over the last couple weeks.He has had an increase in pain, but stated he could not turn his stimulation up because he kept getting a message desired intensity is unavailable.Cs did an impedance check and found that the patient had several contacts that were orange and out of range for a possibly having a short.Patient reprogrammed today without using any of the possibly damaged contacts.Patient was unable to turn stimulation up and down as needed.Patient states that he felt stimulation and low back in both legs.Patient states he will try all three programs to see if he can get his desired relief back.Cs ask patient over the last couple weeks.Did he have a fall or push or pull anything heavy that may have caused damage to his leads.Patient states that he put a new motor in his truck, but said that he used a forklift to help lift the motor.Patient states he doesn¿t know of any other thi ng that he¿s done that could¿ve caused any damage to his leads.Patient states if the new programming does not give him 50% or more relief.It was reported issue was resolved.
|